Patents by Inventor Volker Böttger

Volker Böttger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BINDING EPITOPES FOR G250 ANTIBODY
    Publication number: 20140017252
    Abstract: The invention relates to specific amino acid sequences which have been determined to be target epitope for antibodies, in particular, for a G250 antibody.
    Type: Application
    Filed: July 1, 2013
    Publication date: January 16, 2014
    Applicant: Wilex AG
    Inventors: Thorsten WÖHL, Volker BÖTTGER
  • Binding epitopes for G250 antibody
    Patent number: 8492520
    Abstract: The invention relates to specific amino acid sequences which have been determined to be target epitope for antibodies, in particular, for a G250 antibody.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: July 23, 2013
    Assignee: Wilex AG
    Inventors: Thorsten Wöhl, Volker Böttger
  • BINDING EPITOPES FOR G250 ANTIBODY
    Publication number: 20110123537
    Abstract: The invention relates to specific amino acid sequences which have been determined to be target epitope for antibodies, in particular, for a G250 antibody.
    Type: Application
    Filed: October 31, 2008
    Publication date: May 26, 2011
    Applicant: WILEX AG
    Inventors: Thorsten Wöhl, Volker Böttger
  • Inhibitors of the interaction between P53 and MDM2
    Patent number: 7083983
    Abstract: The present invention relates to compounds capable of binding to the oncogene protein MDM2, processes for the preparation of such compounds, pharmaceutical preparations comprising such compounds, and uses of said compounds, e.g. in the therapeutic (including prophylactic) treatment of an animal or especially of the human body. The present further relates to methods of and compounds for inhibiting the growth of tumor cells which comprise the wild type p53 suppressor by interfering with the interaction between human p53 and human MDM2.
    Type: Grant
    Filed: July 4, 1997
    Date of Patent: August 1, 2006
    Assignee: Cancer Research Campaign Technology Limited
    Inventors: David Philip Lane, Volker Böttger, Angelika Böttger, Steven Michael Picksley, Heinz-Kurt Hochkeppel, Carlos Garcia-Echeverria, Patrick Chène, Pascal Furet